首页> Clinical Pharmacology and Therapeutics> SYSTEMS PHARMACOLOGY MODELING OF HYPOMETHYLATING AGENTS DECITABINE & SGI-110 FOR EVALUATION OF AML TREATMENT BY TARGETING S-PHASE WITH PROLONGED PHARMACOKINETIC EXPOSURES.

SYSTEMS PHARMACOLOGY MODELING OF HYPOMETHYLATING AGENTS DECITABINE & SGI-110 FOR EVALUATION OF AML TREATMENT BY TARGETING S-PHASE WITH PROLONGED PHARMACOKINETIC EXPOSURES.

导出原文传递

翻译打印收藏纠错

第一作者： Oganesian, A.

作者： Oganesian, A. ^[1] ; Demin, O., Jr. ^[2] ; Nikitich, A. ; Demin, O. ; Azab, M.

作者单位： Astex Pharmaceut, Dublin, CA USA ^[1] Inst Syst Biol, Moscow, Russia ^[2]

发布时间 2020-08-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Pharmacology and Therapeutics

2015年97卷S1期

S57-S57页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Clinical Pharmacology and Therapeutics

2015年97卷S1期

S57-S57页

检索历史清除

SYSTEMS PHARMACOLOGY MODELING OF HYPOMETHYLATING AGENTS DECITABINE & SGI-110 FOR EVALUATION OF AML TREATMENT BY TARGETING S-PHASE WITH PROLONGED PHARMACOKINETIC EXPOSURES.

Clinical Pharmacology and Therapeutics

相似文献

同项目论文

Clinical Pharmacology and Therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SYSTEMS PHARMACOLOGY MODELING OF HYPOMETHYLATING AGENTS DECITABINE & SGI-110 FOR EVALUATION OF AML TREATMENT BY TARGETING S-PHASE WITH PROLONGED PHARMACOKINETIC EXPOSURES.

Clinical Pharmacology and Therapeutics

相似文献

同项目论文

Clinical Pharmacology and Therapeutics

相关期刊

检索历史清除